Sunday, Oct 25, 2026
Focus on the big picture

NRx and Israel Developing Covid-19 Vaccine to Attack Variants

Bloomberg, 31 Aug 2021
Aug.30 -- NRx Pharmaceuticals CEO Dr. Jonathan Javitt says they are working with Israel on a Covid-19 vaccine that targets Covid variants. He says vaccines ...
Related Articles